Delfi Diagnostics Company
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Investors
.png)
Funding Status:
Early Stage Venture
Industry:
Biomarkers
Headquarters:
Baltimore, Maryland, United States
Total Funding:
330500000
Last Funding Date:
2022-07-18
Last Funding Type:
Series B
Employee Number:
101-250
Investors Number:
20
Founded Date:
2019-01-01